Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups

Neisseria meningitidis serogroups A, B, C, W, X, and Y cause invasive meningococcal disease (IMD) worldwide. Factor H binding protein (FHbp), a key meningococcal virulence factor, is an antigen included in both licensed meningococcal serogroup B (MenB) vaccines. This review examines the biology and...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenghui Li, Ashlesh Krishna Murthy, Li Hao, Lubomira Andrew, Annaliesa S. Anderson
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2409502
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849687454981816320
author Zhenghui Li
Ashlesh Krishna Murthy
Li Hao
Lubomira Andrew
Annaliesa S. Anderson
author_facet Zhenghui Li
Ashlesh Krishna Murthy
Li Hao
Lubomira Andrew
Annaliesa S. Anderson
author_sort Zhenghui Li
collection DOAJ
description Neisseria meningitidis serogroups A, B, C, W, X, and Y cause invasive meningococcal disease (IMD) worldwide. Factor H binding protein (FHbp), a key meningococcal virulence factor, is an antigen included in both licensed meningococcal serogroup B (MenB) vaccines. This review examines the biology and epidemiology of FHbp and assesses the ability and potential of FHbp vaccine antigens to protect against IMD. Using evidence from the literature and the contemporary PubMLST database, we discuss analyses of MenB genotypes on the representation of the most prevalent multilocus sequence typing (MLST)/clonal complexes, FHbp subfamily distribution, and FHbp and porin A (PorA) variants. We further discuss that the similar genotypes, distribution, and diversity of FHbp variant types have remained stable over long time periods, supporting the potential for FHbp-containing, protein-based vaccines to protect against IMD, including MenB-FHbp (Trumenba®), which contains two lipidated FHbp antigens (one each from both FHbp subfamilies: A and B).
format Article
id doaj-art-72271bbcb41947e1af1ece601ad1857a
institution DOAJ
issn 2164-5515
2164-554X
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj-art-72271bbcb41947e1af1ece601ad1857a2025-08-20T03:22:19ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2409502Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroupsZhenghui Li0Ashlesh Krishna Murthy1Li Hao2Lubomira Andrew3Annaliesa S. Anderson4Pfizer Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USAPfizer Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USAPfizer Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USAPfizer Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USAPfizer Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USANeisseria meningitidis serogroups A, B, C, W, X, and Y cause invasive meningococcal disease (IMD) worldwide. Factor H binding protein (FHbp), a key meningococcal virulence factor, is an antigen included in both licensed meningococcal serogroup B (MenB) vaccines. This review examines the biology and epidemiology of FHbp and assesses the ability and potential of FHbp vaccine antigens to protect against IMD. Using evidence from the literature and the contemporary PubMLST database, we discuss analyses of MenB genotypes on the representation of the most prevalent multilocus sequence typing (MLST)/clonal complexes, FHbp subfamily distribution, and FHbp and porin A (PorA) variants. We further discuss that the similar genotypes, distribution, and diversity of FHbp variant types have remained stable over long time periods, supporting the potential for FHbp-containing, protein-based vaccines to protect against IMD, including MenB-FHbp (Trumenba®), which contains two lipidated FHbp antigens (one each from both FHbp subfamilies: A and B).https://www.tandfonline.com/doi/10.1080/21645515.2024.2409502Vaccinesinvasive meningococcal diseasefactor H binding proteingenotypic diversityclonal complexNeisseria meningitidis
spellingShingle Zhenghui Li
Ashlesh Krishna Murthy
Li Hao
Lubomira Andrew
Annaliesa S. Anderson
Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups
Human Vaccines & Immunotherapeutics
Vaccines
invasive meningococcal disease
factor H binding protein
genotypic diversity
clonal complex
Neisseria meningitidis
title Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups
title_full Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups
title_fullStr Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups
title_full_unstemmed Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups
title_short Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups
title_sort factor h binding protein fhbp an evaluation of genotypic diversity across neisseria meningitidis serogroups
topic Vaccines
invasive meningococcal disease
factor H binding protein
genotypic diversity
clonal complex
Neisseria meningitidis
url https://www.tandfonline.com/doi/10.1080/21645515.2024.2409502
work_keys_str_mv AT zhenghuili factorhbindingproteinfhbpanevaluationofgenotypicdiversityacrossneisseriameningitidisserogroups
AT ashleshkrishnamurthy factorhbindingproteinfhbpanevaluationofgenotypicdiversityacrossneisseriameningitidisserogroups
AT lihao factorhbindingproteinfhbpanevaluationofgenotypicdiversityacrossneisseriameningitidisserogroups
AT lubomiraandrew factorhbindingproteinfhbpanevaluationofgenotypicdiversityacrossneisseriameningitidisserogroups
AT annaliesasanderson factorhbindingproteinfhbpanevaluationofgenotypicdiversityacrossneisseriameningitidisserogroups